终身运动剂量和心室心律失常症在患有 mitra 门缩的患者中
Christian K Five1,2, Nina E Hasselberg1,2, Linda T Aaserud1
1Department of Cardiology, ProCardio Center for Innovation, Oslo University Hospital, Rikshospitalet, PO Box 4950 Nydalen, 0424 Oslo, Norway.
概括
终身运动剂量没有明确的关联与严重的腹腔失常 (VA) 在膜缩 (MVP) 患者. 需要更多的研究来确定MVP患者的安全运动水平,这些患者有VA的风险.
科学领域:
- 心脏病学 心脏病学
- 运动生理学 运动生理学
背景情况:
- 患有中枢脱落 (MVP) 的患者面临危及生命的腹腔失常症 (VA) 的高风险.
- 关于运动对MVP患者心律失常风险的影响的数据有限.
研究的目的:
- 调查MVP患者的终身运动剂量和严重VA之间的关联.
- 探索在MVP中围绕VA事件的确定的风险因素和情况.
主要方法:
- 追溯队列研究包括136名MVP患者.
- 使用代谢等价的任务 (MET) 小时/周来评估终身运动剂量.
- 严重的VA定义为持续的腹腔动脉冲动/,心脏骤停,或适当的ICD休克.
主要成果:
- 在患有和没有严重VA的患者之间,终身运动剂量没有显著差异.
- 在年龄调整之前,终身运动剂量>9.6MET小时/周是严重VA的边界显著标记.
- 心室心律不整事件最常发生在清醒休息期间 (53%),其次是运动 (29%).
结论:
- 在MVP患者中,没有发现中度终身运动剂量与严重的VA之间明显的关联.
- 在MVP中不能排除安全行使水平的上限.
- 需要进一步的研究才能充分理解MVP中运动和严重的VA风险之间的关系.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
19
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
19
Mitral Stenosis II: Clinical features and Diagnostic Tests
22
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
22
Mitral Valve Prolapse I: Introduction
21
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
21
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Mitral Valve Prolapse III: Nursing Management
14
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
14
Mitral Stenosis I: Introduction
15
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
15


